References
- Nordin P, Mobacken HA, Comparison of fusidic acid and flucloxacillin in the treatment of skin and soft-tissue infection. Eur J Clin Res (1994) 5: 97–106.
- Carr WD, Wall AR, Georgala-Zervogiani S et al, Fusidic acid tablets in patients with skin and soft-tissue infection: a dose finding study. Eur J Clin Res (1994) 5: 87–95.
- Verbist L, The antimicrobial activity of fusidic acid. J Antimicrob Chemother (1990) 25 (suppl B): 1–5.
- Blockey NJ, McAllister TA, Antibiotics in acute osteomyelitis in children. J Bone Joint Surg (Br) (1972) 54B: 299–309.
- Learmonth ID, Dall G, Pollock DJ, Antibiotic therapy in acute infections of bone and joints in children. S Afr Med J (1984) 65: 121–2.
- Bourget P, Duchamel J-F, Sorensen H et al, Pharmaco- kinetics of fusidic acid after a single dose of a new paediatric suspension. J Clin Pharm Ther (1993) 18: 171–7. Wise R, Pippard M, The diposition of sodium fusidate in man. J Clin Pharm Ther (1975) 4: 615–19.
- Pharmacokinetics of fusidic acid given in an oral suspension to children. Leo Study FUS 9601 UK. Data on file. LEO Pharma: Ballerup, Denmark.
- MacGowan AP, Greig MA, Andrews JM et al, Pharmaco- kinetics and tolerance of a new film-coated tablet of sodium fusidate administered on a single oral dose to healthy volunteers. J Antimicrob Chemother (1989) 23: 409–15.
- Wall ARJ, Menday AP, Fusidic acid and erythromycin in the treatment of skin and soft tissue infection: a double blind study. J Clin Res (2000) 3: 15–28.
- Morris CDE, Talbot DT, A comparison of sodium fusidate tablets and flucloxacillin capsules in skin and soft tissue infection. J Drug Assessment (2000) 2: 33–46.